180-day exclusivity

180-day exclusivity is a marketing benefit granted to the first generic drug manufacturer that files for approval after the brand-name patent expires. This means that for 180 days, the generic company has exclusive rights to sell its version of the drug, preventing other generic competitors from entering the market. This period is designed to encourage companies to develop affordable alternatives to brand-name medications. It can lead to lower prices once the exclusivity ends, as more generic options become available, enhancing access to necessary medications for consumers.